{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:39:27Z","timestamp":1790645967007,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T00:00:00Z","timestamp":1564099200000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006190","name":"Research and Development","doi-asserted-by":"publisher","award":["JP16bm0609004"],"award-info":[{"award-number":["JP16bm0609004"]}],"id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006190","name":"Research and Development","doi-asserted-by":"publisher","award":["JP16ek0109009"],"award-info":[{"award-number":["JP16ek0109009"]}],"id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006190","name":"Research and Development","doi-asserted-by":"publisher","award":["JP17bm0804008h0001"],"award-info":[{"award-number":["JP17bm0804008h0001"]}],"id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006190","name":"Research and Development","doi-asserted-by":"publisher","award":["JP17am0101122"],"award-info":[{"award-number":["JP17am0101122"]}],"id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008695","name":"Japan Foundation for Applied Enzymology","doi-asserted-by":"publisher","award":["JP26713028"],"award-info":[{"award-number":["JP26713028"]}],"id":[{"id":"10.13039\/100008695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008235","name":"School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004206","name":"Osaka University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004206","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.yjmcc.2018.07.246","type":"journal-article","created":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T14:07:25Z","timestamp":1532354845000},"page":"256-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Generation of Fabry cardiomyopathy model for drug screening using induced pluripotent stem cell-derived cardiomyocytes from a female Fabry patient"],"prefix":"10.1016","volume":"121","author":[{"given":"Yuki","family":"Kuramoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhiko T.","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Tojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamichi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Shibamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akito","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Higo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuki","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Kook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issei","family":"Komuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2018.07.246_bb0005","series-title":"Online Metab. Mol. Bases Inherit. Dis","article-title":"\u03b1-Galactosidase A deficiency: Fabry disease","author":"Desnick","year":"2014"},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0015","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ijcard.2017.06.079","article-title":"Evolution of cardiac pathology in classic Fabry disease: progressive cardiomyocyte enlargement leads to increased cell death and fibrosis, and correlates with severity of ventricular hypertrophy","volume":"248","author":"Frustaci","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0020","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/GIM.0b013e3181bb05bb","article-title":"Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry","volume":"11","author":"Waldek","year":"2009","journal-title":"Genet. Med."},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0025","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jacc.2010.11.018","article-title":"Cardiovascular events in patients with Fabry disease: natural history data from the Fabry Registry","volume":"57","author":"Patel","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0030","first-page":"1","article-title":"Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice","author":"Baig","year":"2017","journal-title":"EP Eur."},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0035","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10545-014-9677-8","article-title":"Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta-analysis: effectiveness of ERT in different disease stages","volume":"37","author":"Rombach","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0040","first-page":"21","article-title":"Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: a Fabry Outcome Survey analysis","volume":"3","author":"Beck","year":"2015","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13023-015-0338-2","article-title":"Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years' treatment","volume":"10","author":"Kampmann","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0050","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jmedgenet-2014-102797","article-title":"Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease","volume":"52","author":"Germain","year":"2015","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0055","first-page":"112","article-title":"Generation of induced pluripotent stem cells from patients with duchenne muscular dystrophy and their induction to cardiomyocytes","author":"Hashimoto","year":"2015","journal-title":"Int. Heart J."},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0060","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ymgme.2013.06.003","article-title":"Morphological features of iPS cells generated from Fabry disease skin fibroblasts using Sendai virus vector (SeVdp)","volume":"109","author":"Kawagoe","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0065","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s10545-014-9724-5","article-title":"Effective clearance of GL-3 in a human iPSC-derived cardiomyocyte model of Fabry disease","volume":"37","author":"Itier","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0070","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijcard.2017.01.009","article-title":"Energy utilization of induced pluripotent stem cell-derived cardiomyocyte in Fabry disease","volume":"232","author":"Chou","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0075","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1006\/bbrc.1995.2416","article-title":"Galactose stabilizes various missense mutants of \u03b1-galactosidase in Fabry disease","volume":"214","author":"Okumiya","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stem.2010.06.003","article-title":"Generation of induced pluripotent stem cells from human terminally differentiated circulating t cells","volume":"7","author":"Seki","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0085","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/stem.1293","article-title":"An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells","volume":"31","author":"Okita","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0090","doi-asserted-by":"crossref","first-page":"19812","DOI":"10.1073\/pnas.0605768103","article-title":"Developmental stage-specific biphasic roles of Wnt\/beta-catenin signaling in cardiomyogenesis and hematopoiesis","volume":"103","author":"Naito","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0095","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.stem.2012.09.013","article-title":"Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes","volume":"12","author":"Tohyama","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0009-8981(81)90384-3","article-title":"Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease","volume":"112","author":"Mayes","year":"1981","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0105","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0021-9673(01)86932-6","article-title":"Separation of lipid classes by high-performance liquid chromatography with the \u201cmass detector\u201d","volume":"361","author":"Christie","year":"1986","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0110","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1172\/JCI200318513","article-title":"Alteration of the 4-sphingenine scaffolds of ceramides in keratinocyte-specific Arnt-deficient mice affects skin barrier function","volume":"112","author":"Takagi","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0115","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0076-6879(06)17012-3","article-title":"Identification and analysis of novel glycolipids in vertebrate brains by HPLC\/mass spectrometry","volume":"417","author":"Nagatsuka","year":"2006","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0120","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0021-9673(04)01095-7","article-title":"Properties of an electrospray emitter coated with material of low surface energy","volume":"1056","author":"Tojo","year":"2004","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0125","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2010.06.024","article-title":"Female human iPSCs retain an inactive X chromosome","volume":"7","author":"Tchieu","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0130","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.stem.2012.02.014","article-title":"Erosion of dosage compensation impacts human iPSC disease modeling","volume":"10","author":"Mekhoubad","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0135","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.stem.2012.02.013","article-title":"Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives","volume":"10","author":"Nazor","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0140","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.cardiores.2005.06.013","article-title":"Expression and regulation of the atrial natriuretic factor encoding gene Nppa during development and disease","volume":"67","author":"Houweling","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0145","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1253\/circj.CJ-12-0987","article-title":"Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture","volume":"77","author":"Kamakura","year":"2013","journal-title":"Circ. J."},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0150","series-title":"Akt Induces Enhanced Myocardial Contractility and Cell Size In Vivo in Transgenic Mice","first-page":"12333","volume":"vol. 99","author":"Condorelli","year":"2002"},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mrgentox.2015.04.012","article-title":"DNA damage in Fabry patients: an investigation of oxidative damage and repair","volume":"784\u2013785","author":"Biancini","year":"2015","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0160","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ymgme.2011.06.007","article-title":"Higher apoptotic state in Fabry disease peripheral blood mononuclear cells. Effect of globotriaosylceramide","volume":"104","author":"De Francesco","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0165","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.humpath.2015.07.017","article-title":"Increased oxidative stress contributes to cardiomyocyte dysfunction and death in patients with Fabry disease cardiomyopathy","volume":"46","author":"Chimenti","year":"2015","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0170","doi-asserted-by":"crossref","first-page":"87161","DOI":"10.18632\/oncotarget.13552","article-title":"Interleukin-18 deteriorates Fabry cardiomyopathy and contributes to the development of left ventricular hypertrophy in Fabry patients with GLA IVS4+919 G>A mutation","volume":"7","author":"Chien","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0175","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cge.12613","article-title":"X-chromosome inactivation in female patients with Fabry disease","volume":"89","author":"Echevarria","year":"2016","journal-title":"Clin. Genet."},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0180","first-page":"1","article-title":"Long-term pathological follow-up of myocardium in a carrier of duchenne muscular dystrophy with dilated cardiomyopathy","volume":"10","author":"Kondo","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0185","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bbalip.2013.08.019","article-title":"Ceramide synthases as potential targets for therapeutic intervention in human diseases","volume":"1841","author":"Park","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0190","article-title":"Lipotoxic very-long-chain ceramides cause mitochondrial dysfunction, oxidative stress, and cell death in cardiomyocytes","author":"Law","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0144958","article-title":"Distributions of globotriaosylceramide isoforms, and globotriaosylsphingosine and its analogues in an alpha-galactosidase a knockout mouse, a model of fabry disease","volume":"10","author":"Sueoka","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0200","author":"Linhart"},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0205","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nature10147","article-title":"Heart regeneration","volume":"473","author":"Laflamme","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0210","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1510198","article-title":"Treatment of Fabry's disease with the pharmacologic chaperone migalastat","volume":"375","author":"Germain","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2018.07.246_bb0215","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/1875397301004010067","article-title":"High throughput screening for inhibitors of alpha-galactosidase","volume":"4","author":"Motabar","year":"2010","journal-title":"Curr. Chem. Genomics"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818306874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818306874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:25:51Z","timestamp":1758313551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282818306874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":43,"alternative-id":["S0022282818306874"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2018.07.246","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of Fabry cardiomyopathy model for drug screening using induced pluripotent stem cell-derived cardiomyocytes from a female Fabry patient","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2018.07.246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}